We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.06%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNC
2901
DELISTED
GNC Holdings, Inc.
GNC
$222K ﹤0.01%
26,385
+14,315
+119% +$108K
DCUC
2902
DELISTED
Dominion Energy, Inc.
DCUC
$222K ﹤0.01%
+4,647
New +$234K
ATEX icon
2903
Anterix
ATEX
$1.96B
$221K ﹤0.01%
9,505
-100
-1% -$2.32K
ADAM
2904
Adamas Trust
ADAM
$856M
$221K ﹤0.01%
8,901
-265
-3% -$6.67K
FRME icon
2905
First Merchants
FRME
$2.69B
$220K ﹤0.01%
5,491
-162
-3% -$6.54K
TSI
2906
TCW Strategic Income Fund
TSI
$212M
$220K ﹤0.01%
38,952
-45,056
-54% -$249K
NEN icon
2907
New England Realty Associates
NEN
$196M
$219K ﹤0.01%
3,060
TCRT icon
2908
Alaunos Therapeutics
TCRT
$4.86M
$219K ﹤0.01%
235
-7
-3% -$6.86K
OIG
2909
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$219K ﹤0.01%
1,425
XLPS
2910
DELISTED
POWERSHARES S&P SMALLCAP CONSUMER STAPLES PORT
XLPS
$219K ﹤0.01%
3,285
-3
-0.1% -$200
AUB icon
2911
Atlantic Union Bankshares
AUB
$6.02B
$218K ﹤0.01%
6,444
-4,734
-42% -$161K
LDL
2912
DELISTED
Lydall, Inc.
LDL
$218K ﹤0.01%
+4,209
New +$217K
MPC icon
2913
CALL
Marathon Petroleum
MPC
$84B
$217K ﹤0.01%
191,000
+57,900
+44% +$2.99M
CRR
2914
DELISTED
Carbo Ceramics Inc.
CRR
$217K ﹤0.01%
+31,725
New +$261K
CMF icon
2915
iShares California Muni Bond ETF
CMF
$4.61B
$216K ﹤0.01%
+3,668
New +$215K
NATR icon
2916
Nature's Sunshine
NATR
$358M
$216K ﹤0.01%
16,275
+1,050
+7% +$11.9K
ARES icon
2917
Ares Management
ARES
$31.2B
$215K ﹤0.01%
11,921
+1,224
+11% +$22.7K
ARR
2918
Armour Residential REIT
ARR
$2.34B
$215K ﹤0.01%
+1,718
New +$216K
CTSO icon
2919
Cytosorbents Corp
CTSO
$25M
$215K ﹤0.01%
50,000
+24,558
+97% +$108K
CHU
2920
DELISTED
China Unicom (HONG KONG) Limited
CHU
$215K ﹤0.01%
14,353
+3,066
+27% +$42.7K
THC icon
2921
Tenet Healthcare
THC
$20.7B
$214K ﹤0.01%
+11,065
New +$193K
BKF icon
2922
iShares MSCI BIC ETF
BKF
$78.1M
$213K ﹤0.01%
5,693
-22
-0.4% -$815
CBT icon
2923
Cabot Corp
CBT
$4.52B
$213K ﹤0.01%
+3,979
New +$218K
DTH icon
2924
WisdomTree International High Dividend Fund
DTH
$658M
$213K ﹤0.01%
5,112
-465
-8% -$19.4K
SYLD icon
2925
Cambria Shareholder Yield ETF
SYLD
$1.01B
$213K ﹤0.01%
6,232

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.